Work

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions

Year: 2014
Type: review
Abstract: Parkinsonian diseases comprise a heterogeneous group of neurodegenerative disorders, which show significant clinical and pathological overlap. Accurate diagnosis still largely relies on clinical acumen; pathological diagnosis remains the gold standard. There is an urgent need for biomarkers to diagnose parkinsonian disorders, particularly in the early stages when diagnosis is most difficult. In this review, several of the most promising cerebrospinal fluid candidate markers will be discussed. Their strengths and limitations will be considered together with future developments in the field.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $2,600
OpenAlex ID: W2104758750
FWCI: 1.804
Cites: 104
Cited by: 102
Related to: 10